Williams R S, Lefkowitz R J
Circ Res. 1978 Nov;43(5):721-7. doi: 10.1161/01.res.43.5.721.
[3H]Dihydroergocryptine ([3H]DHE) binds to sites in membranes derived from rat myocardium that have the characteristics expected of alpha-adrenergic receptors. The binding is saturable with 41 fmol [3H]DHE bound per mg of protein and of high affinity with KD = 2.9 nM. The binding is rapid and readily reversible. Adrenergic agonists compete with [3H]DHE for binding in the order: epinephrine greater than norepinephrine greater than isoproterenol; and adrenergic antagonists compete for binding in the order: phentolamine greater than propranolol. For comparison, (-)[3H]dihydroalprenolol [(-)[3h]dha] was used to bind to sites in the same membrane preparations having characteristics of beta-receptors. The number and affinity of beta-receptors were quite similar to those of the alpha-receptors with 46 fmol (-)[EH]DHA per mg protein bound at saturation and KD = 2.5 nM. These techniques allowed identification of both beta- and alpha-adrenergic receptors in membranes derived from isolated atria, right ventricular free walls, and left ventricles including interventricular septa. This is the first report documenting direct identification of myocardial alpha-receptors by radioligand-binding techniques and complements the literature previously reporting myocardial inotopic and electrophysiological responses to alpha-adrenergic stimulation.
[3H]二氢麦角隐亭([3H]DHE)与源自大鼠心肌的膜上的位点结合,这些位点具有α-肾上腺素能受体所预期的特征。结合具有饱和性,每毫克蛋白质结合41飞摩尔[3H]DHE,且具有高亲和力,解离常数KD = 2.9纳摩尔。结合迅速且易于逆转。肾上腺素能激动剂与[3H]DHE竞争结合的顺序为:肾上腺素>去甲肾上腺素>异丙肾上腺素;肾上腺素能拮抗剂竞争结合的顺序为:酚妥拉明>普萘洛尔。为作比较,使用(-)-[3H]二氢烯丙洛尔[(-)-[3H]DHA]与具有β受体特征的相同膜制剂中的位点结合。β受体的数量和亲和力与α受体相当相似,饱和时每毫克蛋白质结合46飞摩尔(-)-[3H]DHA,KD = 2.5纳摩尔。这些技术使得能够在源自分离的心房、右心室游离壁以及包括室间隔的左心室的膜中鉴定出β和α肾上腺素能受体。这是首篇通过放射性配体结合技术直接鉴定心肌α受体的报告,补充了先前报道心肌对α肾上腺素能刺激的变力性和电生理反应的文献。